Ghisallo Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$1.24M 181
2023
Q4
$1.24M Hold
20,000
0.13% 95
2023
Q3
$444K Buy
+20,000
New +$420K 0.05% 100

Ghisallo Capital Management's RYZB Position: Q1 2024 in Review

Ghisallo Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.24M sold.

Ghisallo Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $1.24M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Ghisallo Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ghisallo Capital Management sold 20,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.24M.
  • Ghisallo Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Ghisallo Capital Management's RayzeBio, Inc. Common Stock position peaked at $1.24M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Ghisallo Capital Management's 13F filing for Q1 2024, filed 15 May 2024.